FindTrial
Sign In

Gallbladder cancer tumour sequencing study

To elucidate geographical differences in the incidence of gallbladder cancer by identifying etiologically distinct types of gallbladder cancer through the study of mutational signature.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/07/020307
Enrollment
100
Registered
2019-07-22
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C23- Malignant neoplasm of gallbladder

Interventions

None listed

Sponsors

Tata Memorial Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.primary gallbladder cancer (C.23) (International Classification of Diseases for Oncology Version 3 [ICDO-3]) 2. Date of diagnosis more than 6 months from the date of enrollment 3.a resident of India for at least one year

Exclusion criteria

Exclusion criteria: 1.Patient with malignancies arising from the ampulla of Vater(C24.1), overlapping lesions of the biliary tract (C24.8), 2unspecified regions of the biliary tract (C24.9), and any other malignancies (International Classification of Diseases for Oncology Version 3 [ICD-O-3]) 2.Pregnant females

Design outcomes

Primary

MeasureTime frame
mutational signatureTimepoint: two years—

Secondary

MeasureTime frame
nilTimepoint: nil—

Countries

India

Contacts

Public ContactDr Rajesh Dikshit

Centre For Cancer Epidemiology

dixr24@hotmail.com09969518844

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026